Debela, D.T.; Muzazu, S.G.Y.; Heraro, K.D.; Ndalama, M.T.; Mesele, B.W.; Haile, D.C.; et al. New approaches and procedures for cancer treatment: Current perspectives; SAGE Publications Ltd: 2021.
Al-Hamashi, A.A.; Koranne, R.; Dlamini, S.; Alqahtani, A.; Karaj, E.; Rashid, M.S.; et al. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics. Bioorganic Chemistry Academic Press Inc.: 2021, 116.
Saeed, A.M.; Al-Hamashi, A.A.A. Molecular Docking, ADMET Study, Synthesis, Characterization, and Preliminary Antiproliferative Activity of Potential Histone Deacetylase Inhibitors with Isoxazole as New Zinc Binding Group. Iraqi Journal of Pharmaceutical Sciences University of Baghdad - College of Pharmacy: 2023, 32, 188–203.
Davalos, V.; Esteller, M. Cancer epigenetics in clinical practice. CA: A Cancer Journal for Clinicians Wiley: 2023, 73(4), 376–424.
Wu, Y.; Sarkissyan, M.; Vadgama, J. V. Epigenetics in breast and prostate cancer. Methods in Molecular Biology Humana Press Inc.: 2015, 1238, 425–466.
Mohammed, N.M.; Mohammed, M.H.; Abdulkhaleq, Z.M. Docking Study, Synthesis, Characterization and Preliminary Cytotoxic Evaluation of New 1,3,4-Thiadiazole Derivatives. J Contemp Med Sci | n.d., 9(4), 271–279.
Ramaiah, M.J.; Tangutur, A.D.; Manyam, R.R. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy; Elsevier Inc.: 2021.
Kulthinee, S.; Yano, N.; Zhuang, S.; Wang, L.; Zhao, T.C. Critical Functions of Histone Deacetylases (HDACs) in Modulating Inflammation Associated with Cardiovascular Diseases; MDPI: 2022, 471–485.
Mohessen Mosa, H.; Abed, A.; Al-Hamashi, A. Oncology and Radiotherapy© Design, synthesis, and antiproliferative activity evaluation of novel N-hydroxyurea derivatives as possible dual HDAC-BET inhibitors; 2024.
Roshdy, E.; Mustafa, M.; Shaltout, A.E.R.; Radwan, M.O.; Ibrahim, M.A.A.; Soliman, M.E.; et al. Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020; Elsevier Masson s.r.l.: 2021.
Mohammad, Y.; Al-Hamashi, A. Oncology and Radiotherapy© Design, synthesis, and evaluation of activity against breast cancer cells of new naphthalene derivatives as potential sirtuin enzymes inhibitors; 2024.
HASAN, Y.; AL-HAMASHİ, A. Identification of Selisistat Derivatives as SIRT1-3 Inhibitors by in Silico Virtual Screening. Turkish Computational and Theoretical Chemistry Turkish Computational and Theoretical Chemistry: 2023, 8(2), 1–11.
Mautone, N.; Zwergel, C.; Mai, A.; Rotili, D. Sirtuin modulators: where are we now? A review of patents from 2015 to 2019; Taylor and Francis Ltd: 2020, 389–407.
Ronchetti, R.; Moroni, G.; Carotti, A.; Gioiello, A.; Camaioni, E. Recent advances in urea- And thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis; Royal Society of Chemistry: 2021, 1046–1064.
Viswas, R.S.; Pundir, S.; Lee, H. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. Journal of Enzyme Inhibition and Medicinal Chemistry Taylor and Francis Ltd: 2019, 34(1), 620–630.
Zhao, X.; Allison, D.; Condon, B.; Zhang, F.; Gheyi, T.; Zhang, A.; et al. The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD + ) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. Journal of Medicinal Chemistry American Chemical Society: 2013, 56(3), 963–969.
Yang, L.L.; Wang, H.L.; Zhong, L.; Yuan, C.; Liu, S.Y.; Yu, Z.J.; et al. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. European Journal of Medicinal Chemistry Elsevier Masson s.r.l.: 2018, 155, 806–823.
Disch, J.S.; Evindar, G.; Chiu, C.H.; Blum, C.A.; Dai, H.; Jin, L.; et al. Discovery of thieno[3,2-d ]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3. Journal of Medicinal Chemistry 2013, 56(9), 3666–3679.
Friesner, R.A.; Murphy, R.B.; Repasky, M.P.; Frye, L.L.; Greenwood, J.R.; Halgren, T.A.; et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry 2006, 49(21), 6177–6196.
Halgren, T.A.; Murphy, R.B.; Friesner, R.A.; Beard, H.S.; Frye, L.L.; Pollard, W.T.; et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. Journal of Medicinal Chemistry 2004, 47(7), 1750–1759.
Mohammed, Z.M.; Abed, A.; Al-Hamashi, A. MOLECULAR DOCKING, ADMET, AND MOLECULAR DYNAMICS SIMULATION STUDIES FOR MOLECULES WITH EXPECTED HDAC INHIBITION ACTIVITY. Gomal Journal of Medical n.d., 22(2), 164.
Friesner, R.A.; Banks, J.L.; Murphy, R.B.; Halgren, T.A.; Klicic, J.J.; Mainz, D.T.; et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. Journal of Medicinal Chemistry 2004, 47(7), 1739–1749.
Boss, C.; Hazemann, J.; Kimmerlin, T.; Korff, M. Von; Lüthi, U.; Peter, O.; et al. The screening compound collection: A key asset for drug discovery. Chimia Swiss Chemical Society: 2017, 71(10), 667–677.
Rajagopal, K.; Kalusalingam, A.; Bharathidasan, A.R.; Sivaprakash, A.; Shanmugam, K.; Sundaramoorthy, M.; et al. In Silico Drug Design of Anti-Breast Cancer Agents. Molecules MDPI: 2023, 28(10).
Hussien, M.S.; Al-Hamashi, A.A. Phytosterol Profile in Iraqi Lactuca serriola after Purification and Isolation by Combiflash and HPLC; In Iraqi Journal of Pharmaceutical Sciences; University of Baghdad - College of Pharmacy: 2022, 54–61.
Shakeel, A. Thiourea Derivatives in Drug Design and Medicinal Chemistry: A Short Review. Journal of Drug Design and Medicinal Chemistry Science Publishing Group: 2016, 2(1), 10.
Shulgau, Z.; Palamarchuk, I.; Sergazy, S.; Urazbayeva, A.; Gulyayev, A.; Ramankulov, Y.; et al. Synthesis, Computational Study, and In Vitro α-Glucosidase Inhibitory Action of Thiourea Derivatives Based on 3-Aminopyridin-2(1H)-Ones. Molecules 2024, 29(15), 3627.
Ghosh, A.K.; Shahabi, D. Synthesis of amide derivatives for electron deficient amines and functionalized carboxylic acids using EDC and DMAP and a catalytic amount of HOBt as the coupling reagents. Tetrahedron Letters Elsevier Ltd: 2021, 63.
Ghorab, M.M.; Alsaid, M.S.; El-Gaby, M.S.A.; Elaasser, M.M.; Nissan, Y.M. Antimicrobial and anticancer activity of some novel fluorinated thiourea derivatives carrying sulfonamide moieties: Synthesis, biological evaluation and molecular docking. Chemistry Central Journal BioMed Central Ltd.: 2017, 11(1).
Li, C.; Zhou, Y.; Kim, J.T.; Sengoku, T.; Alstott, M.C.; Weiss, H.L.; et al. Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells. Biochimica et Biophysica Acta - Molecular Cell Research Elsevier B.V.: 2021, 1868(4).
Comments (0)